Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers

Krüppel‐like factor (KLF) 6 is a candidate tumor suppressor gene in prostate cancer, but the mechanisms contributing to its loss of expression are poorly understood. We characterized KLF6 expression and DNA methylation status during prostate tumorigenesis in humans and mice.

[1]  D. Horsfall,et al.  Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. , 1994, Cancer research.

[2]  J. Rosen,et al.  Metastatic prostate cancer in a transgenic mouse. , 1996, Cancer research.

[3]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Friedman,et al.  KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer , 2001, Science.

[5]  J. Bieker.  Krüppel-like Factors: Three Fingers in Many Pies* , 2001, The Journal of Biological Chemistry.

[6]  F. Sato,et al.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.

[7]  Alexander Dobrovic,et al.  Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. , 2002, Carcinogenesis.

[8]  H. Frierson,et al.  Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. , 2003, The American journal of pathology.

[9]  M. Hollstein,et al.  Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes , 2003, British Journal of Cancer.

[10]  S. Friedman,et al.  Krüppel cripples prostate cancer: KLF6 progress and prospects. , 2003, The American journal of pathology.

[11]  W. Gerald,et al.  Gene expression profiling predicts clinical outcome of prostate cancer. , 2004, The Journal of clinical investigation.

[12]  J. Schleutker,et al.  Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer. , 2004, The Journal of urology.

[13]  E. Latulippe,et al.  Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. , 2004, The American journal of pathology.

[14]  G. Ito,et al.  Krüppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.

[15]  S. Friedman,et al.  Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6 , 2004, Oncogene.

[16]  S. Friedman,et al.  Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1 , 2004, Cancer Research.

[17]  Eeva Kettunen,et al.  Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. , 2004, Cancer genetics and cytogenetics.

[18]  J. Veltman,et al.  Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines , 2004, Genes, chromosomes & cancer.

[19]  D. Horsfall,et al.  Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non‐organ confined disease , 2005, The Prostate.

[20]  J. Bocco,et al.  Genomic organization and functional analysis of the gene encoding the Krüppel-like transcription factor KLF6. , 2005, Biochimica et biophysica acta.

[21]  J. Zucman‐Rossi,et al.  Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers , 2005, Oncogene.

[22]  D. Schaid,et al.  A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. , 2005, Cancer research.

[23]  S. Boyault,et al.  Absence of KLF6 gene mutation in 71 hepatocellular carcinomas , 2005, Hepatology.

[24]  S. Friedman,et al.  Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. , 2005, Cancer research.

[25]  W. Park,et al.  Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma , 2006, Journal of gastroenterology and hepatology.

[26]  M. Becich,et al.  Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process , 2007, BMC Cancer.

[27]  D. Bercovich,et al.  Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6 , 2006, The Prostate.

[28]  Makoto Arai,et al.  Methylation Status of Genes Upregulated by Demethylating Agent 5-aza-2′-Deoxycytidine in Hepatocellular Carcinoma , 2007, Oncology.

[29]  T. Golub,et al.  Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. , 2006, Cancer research.

[30]  S. Friedman,et al.  Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination , 2006, Clinical Cancer Research.

[31]  W. Park,et al.  Aberrant expression of krUppel-like factor 6 protein in colorectal cancers. , 2006, World journal of gastroenterology.

[32]  KLF6: mutational analysis and effect on cancer cell proliferation. , 2007, International journal of oncology.

[33]  W. Gerald,et al.  Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. , 2007, Cancer research.

[34]  S. Friedman,et al.  Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma , 2007, International journal of cancer.

[35]  J. Schleutker,et al.  KLF6 IVS1 -27G>A variant and the risk of prostate cancer in Finland. , 2007, European urology.

[36]  M. Zhuang,et al.  Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines. , 2008, The Tohoku journal of experimental medicine.

[37]  Merlin Crossley,et al.  Krüppel-like transcription factors: a functional family. , 2008, The international journal of biochemistry & cell biology.

[38]  S. Serrano,et al.  KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations , 2008, Modern Pathology.

[39]  H. Friess,et al.  Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. , 2008, European journal of cancer.

[40]  D. Horsfall,et al.  Elevated levels of HER‐2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential , 2008, The Prostate.

[41]  S. Dhanasekaran,et al.  KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. , 2008, The Journal of clinical investigation.

[42]  Xia Li,et al.  KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3* , 2008, Journal of Biological Chemistry.

[43]  J. Zha,et al.  Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway* , 2009, The Journal of Biological Chemistry.

[44]  S. Friedman,et al.  Functional role of the KLF6 tumour suppressor gene in gastric cancer. , 2009, European journal of cancer.

[45]  J. Martignetti,et al.  The role of KLF6 and its splice variants in cancer therapy. , 2009, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[46]  W. Gerald,et al.  Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[47]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[48]  K. Chiam,et al.  GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells , 2011, PloS one.

[49]  S. Kulp,et al.  Energy Restriction-mimetic Agents Induce Apoptosis in Prostate Cancer Cells in Part through Epigenetic Activation of KLF6 Tumor Suppressor Gene Expression* , 2011, The Journal of Biological Chemistry.